Plain-English Summary
Microplastics in placenta in Human placenta samples analyzed after delivery. Placenta detection makes developmental exposure a credible concern.
VV Study Evidence Matrix v1.0
VV Evidence Utility Score
A bounded score for how useful this study is in public explanation, based on evidence tier, design, applicability, endpoint relevance, limitations, safety signals, and publication/source strength.
65/100
Limited Public Evidence
- Evidence tier
- 66/100, weight 18%
- Design strength
- 66/100, weight 18%
- Applicability
- 62/100, weight 16%
- Endpoint relevance
- 58/100, weight 16%
- Limitations transparency
- 60/100, weight 12%
- Safety signal usefulness
- 57/100, weight 10%
- Publication/source strength
- 88/100, weight 10%
Useful for context, but limited by safety signal usefulness, endpoint relevance, limitations transparency.
How the study framework works ->Key Findings
- Placenta detection makes developmental exposure a credible concern.
- It does not by itself quantify fetal risk.
Limitations
- Small sample and measurement-sensitive methods.
- Outcome effects were not directly measured.
Why It Matters
Detection of microplastic particles in placenta.
Viral Vitalism Verdict
Useful evidence, bounded by design: Small sample and measurement-sensitive methods.
Sources
- Plasticenta: first evidence of microplastics in human placenta - Environment International
Signal cards
Used in signals
Signal coverage connected to this study through explicit study links, canonical source refs, or evidence visualizations.
Microplastics, BPA, and Phthalates: Endocrine Panic or Real Exposure Signal?
Microplastics, BPA, and phthalates sit between real environmental-health concern and viral endocrine panic. The credible path is to separate exposure, biomonitoring, mechanistic plausibility, fertility signals, cardiovascular findings, and practical reduction from certainty theater.
VV Signal Score
57
Early or context-dependent
- Sources
- 7
- Studies
- 7
- Claims
- 5